Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation

American Journal of Physiology - Gastrointestinal and Liver Physiology - Tập 287 Số 1 - Trang G7-G17 - 2004
Steven H. Itzkowitz1, Xianyang Yio1
1Gastrointestinal Division, Mount Sinai School of Medicine, New York, New York 10029

Tóm tắt

Patients with ulcerative colitis and Crohn's disease are at increased risk for developing colorectal cancer. To date, no known genetic basis has been identified to explain colorectal cancer predisposition in these inflammatory bowel diseases. Instead, it is assumed that chronic inflammation is what causes cancer. This is supported by the fact that colon cancer risk increases with longer duration of colitis, greater anatomic extent of colitis, the concomitant presence of other inflammatory manifestations such as primary sclerosing cholangitis, and the fact that certain drugs used to treat inflammation, such as 5-aminosalicylates and steroids, may prevent the development of colorectal cancer. The major carcinogenic pathways that lead to sporadic colorectal cancer, namely chromosomal instability, microsatellite instability, and hypermethylation, also occur in colitis-associated colorectal cancers. Unlike normal colonic mucosa, however, inflamed colonic mucosa demonstrates abnormalities in these molecular pathways even before any histological evidence of dysplasia or cancer. Whereas the reasons for this are unknown, oxidative stress likely plays a role. Reactive oxygen and nitrogen species produced by inflammatory cells can interact with key genes involved in carcinogenic pathways such as p53, DNA mismatch repair genes, and even DNA base excision-repair genes. Other factors such as NF-κB and cyclooxygenases may also contribute. Administering agents that cause colitis in healthy rodents or genetically engineered cancer-prone mice accelerates the development of colorectal cancer. Mice genetically prone to inflammatory bowel disease also develop colorectal cancer especially in the presence of bacterial colonization. These observations offer compelling support for the role of inflammation in colon carcinogenesis.

Từ khóa


Tài liệu tham khảo

10.1016/S0002-9440(10)64587-7

Ahn Band Ohshima H.Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production.Cancer Res61: 8357–8360, 2001.

Arai N, Mitomi H, Ohtani Y, Igarashi M, Kakita A, and Okayasu I.Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis.Mod Pathol12: 604–611, 1999.

10.1002/cncr.10334

10.1016/S0002-9440(10)61172-8

10.1152/ajpgi.00309.2003

10.1172/JCI118861

Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, and Srivastava S.A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.Cancer Res58: 5248–5257, 1998.

Brentnall TA, Crispin DA, Bronner MP, Cherian SP, Hueffed M, Rabinovitch PS, Rubin CE, Haggitt RC, and Boland CR.Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis.Cancer Res56: 1237–1240, 1996.

10.1016/0016-5085(94)90161-9

10.1016/0016-5085(95)90280-5

Bull AW.The role of peroxisome proliferator-activated receptor gamma in colon cancer and inflammatory bowel disease.Arch Pathol Lab Med127: 1121–1123, 2003.

10.1016/0016-5085(92)91184-6

10.1046/j.1365-2036.1999.00652.x

10.1152/ajpcell.00422.2001

10.1016/S0002-9440(10)63860-6

10.1158/0008-5472.CAN-03-2272

10.1053/gast.2001.29609

10.1093/carcin/21.4.757

10.1038/nature01322

10.1007/s00384-002-0476-6

Crowell JA, Steele VE, Sigman CC, and Fay JR.Is inducible nitric oxide synthase a target for chemoprevention?Mol Cancer Ther2: 815–823, 2003.

10.1097/00054725-200401000-00003

10.1016/S0016-5085(03)00271-3

Eaden J, Abrams K, Ekbom A, Jackson E, and Mayberry J.Colorectal cancer prevention in ulcerative colitis: a case-control study.Aliment Pharmacol Ther14: 145–153, 2000.

Engle SJ, Hoying JB, Boivin GP, Ormsby I, Gartside PS, and Doetschman T.Transforming growth factor β1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis.Cancer Res59: 3379–3386, 1999.

Engle SJ, Ormsby I, Pawlowski S, Boivin GP, Croft J, Balish E, and Doetschman T.Elimination of colon cancer in germ-free transforming growth factor β1-deficient mice.Cancer Res62: 6362–6326, 2002.

10.1016/S0002-9440(10)63863-1

Erdman SE, Rao VP, Poutahidis T, Ihrig MM, Ge Z, Feng Y, Tomczak M, Rogers AB, Horwitz BH, and Fox JG.CD4+CD25+regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice.Cancer Res63: 6042–6250, 2003.

10.1001/jama.291.5.585

Fleisher AS, Esteller M, Harpaz N, Leytin A, Rashid A, Xu Y, Liang J, Stine OC, Yin J, Zou TT, Abraham JM, Kong D, Wilson KT, James SP, Herman JG, and Meltzer SJ.Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene,hMLH1.Cancer Res60: 4864–4868, 2000.

10.1038/35070129

Gasche C, Chang CL, Rhees J, Goel A, and Boland CR.Oxidative stress increases frameshift mutations in human colorectal cancer cells.Cancer Res61: 7444–7448, 2001.

10.1053/bega.2002.0353

10.1097/00054725-200307000-00003

10.1126/science.270.5239.1203

10.1007/s005350200060

Hisamatsu T, Watanabe M, Ogata H, Ezaki T, Hozawa S, Ishii H, Kanai T, and Hibi T.Interferon-inducible gene family 1–8U expression in colitis-associated colon cancer and severely inflamed mucosa in ulcerative colitis.Cancer Res59: 5927–5931, 1999.

10.1172/JCI19757

10.1073/pnas.0237083100

10.1016/S0891-5849(01)00565-2

Hsieh CJ, Klump B, Holzmann K, Borchard F, Gregor M, and Porschen R.Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis.Cancer Res58: 3942–3945, 1998.

Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, and Harris CC.Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease.Cancer Res60: 3333–3337, 2000.

Hussain SP, Hofseth LJ, and Harris CC.Radical causes of cancer.Nature Rev Cancer276: 276–285, 2003.

Issa JP, Ahuja N, Toyota M, Bronner MP, and Brentnall TA.Accelerated age-related CpG island methylation in ulcerative colitis.Cancer Res61: 3573–3577, 2001.

10.1016/S0889-8553(02)00047-X

Itzkowitz SHand Harpaz N.Diagnosis and management of dysplasia in patients with inflammatory bowel disease.Gastroenterology126: 2004. In press.

10.1053/gast.2002.35392

Kado S, Uchida K, Funabashi H, Iwata S, Nagata Y, Ando M, Onoue M, Matsuoka Y, Ohwaki M, and Morotomi M.Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor β chain and p53 double-knockout mice.Cancer Res61: 2395–2398, 2001.

10.1136/gut.42.2.180

Kohonen-Corish MR, Daniel JJ, te Riele H, Buffinton GD, and Dahlstrom JE.Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors.Cancer Res62: 2092–2097, 2002.

10.1007/s003840100311

10.1093/carcin/21.3.361

10.1097/00054725-200311000-00002

10.1172/JCI118757

10.1136/gut.44.2.180

10.1146/annurev.immunol.19.1.683

Niho N, Takahashi M, Kitamura T, Shoji Y, Itoh M, Noda T, Sugimura T, and Wakabayashi K.Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands.Cancer Res63: 6090–6095, 2003.

10.1023/A:1005433231058

10.1016/S0046-8177(99)90293-9

10.1046/j.1440-1746.2002.02853.x

10.1046/j.1365-2036.2001.01027.x

10.1038/ng989

10.1016/0016-5085(94)90068-X

Rabinovitch PS, Dziadon S, Brentnall TA, Emond MJ, Crispin DA, Haggitt RC, and Bronner MP.Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis.Cancer Res59: 5148–5153, 1999.

10.1136/gut.36.5.718

10.1016/0016-5085(93)91063-N

10.1016/0016-5085(95)90064-0

Ricciardiello L, Baglioni M, Giovannini C, Pariali M, Cenacchi G, Ripalti A, Landini MP, Sawa H, Nagashima K, Frisque RJ, Goel A, Boland CR, Tognon M, Roda E, and Bazzoli F.Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus.Cancer Res63: 7256–7262, 2003.

Ritland SR, Leighton JA, Hirsch RE, Morrow JD, Weaver AL, and Gendler SJ.Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.Clin Cancer Res5: 855–863, 1999.

10.1016/S0016-5085(98)70202-1

10.1016/0016-5085(92)91185-7

10.1038/ng0695-143

10.1053/j.gastro.2003.11.010

10.7326/0003-4819-134-7-200104030-00011

Sato F, Harpaz N, Shibata D, Xu Y, Yin J, Mori Y, Zou TT, Wang S, Desai K, Leytin A, Selaru FM, Abraham JM, and Meltzer SJ.Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis.Cancer Res62: 1148–1151, 2002.

10.1093/carcin/23.6.993

10.1093/carcin/24.3.353

10.1016/S0016-5085(00)70216-2

Sohn KJ, Shah SA, Reid S, Choi M, Carrier J, Comiskey M, Terhorst C, and Kim YI.Molecular genetics of ulcerative colitis-associated colon cancer in the interleukin 2- and β2-microglobulin-deficient mouse.Cancer Res61: 6912–6917, 2001.

Steele VE, Hawk ET, Viner JL, and Lubet RA.Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer.Mutat Res523–524: 137–144, 2003.

10.1093/carcin/22.4.665

10.1172/JCI7145

Tarmin L, Yin J, Harpaz N, Kozam M, Noordzij J, Antonio LB, Jiang HY, Chan O, Cymes K, and Meltzer SJ.Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms.Cancer Res55: 2035–2038, 1995.

10.1073/pnas.96.15.8681

10.1111/j.1349-7006.1999.tb00681.x

10.1016/S0002-9440(10)65438-7

10.1172/JCI11914

10.1016/0016-5085(93)90639-T

Thông tin
Thông tin xuất bản

American Journal of Physiology - Gastrointestinal and Liver Physiology

Tập 287 Số 1

G7-G17

Thông tin tác giả